Latest / Off the Chart: A Business of Medicine Podcast
Breakthroughs in Atopic Dermatitis, with Linda Stein Gold, MD
Linda Stein Gold, MD, FAAD, discusses the late-breaking tapinarof cream 1% data from a new analysis of the ADORING-3 clinical trial. Interview recorded at the 2025 American Academy of Dermatology conference in Orlando, Florida.
Topics discussed include:
Key insights from the new analysis of the ADORING-3 clinical trial on the use of tapinarof cream, 1% in patients with atopic dermatitis.
Long-term safety and efficacy of tapinarof cream.
How tapinarof cream differs from existing treatment options.
Impacts on clinical practice.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.